p120(ctn) acts as an inhibitory regulator of cadherin function in colon carcinoma cells. Aono S, Nakagawa S, Reynolds AB, Takeichi M (1999) J Cell Biol 145: 551-62 PTH induction of transcriptional activity of the cAMP response element-binding protein requires the serine 129 site and glycogen synthase kinase-3 activity, but not casein kinase II sites. Tyson DR, Swarthout JT, Jefcoat SC, Partridge NC (2002) Endocrinology 143: 674-82 Exploiting mechanistic differences between drug classes to define functional drug interaction domains on topoisomerase II. Evidence that several diverse DNA cleavage-enhancing agents share a common site of action on the enzyme. Corbett AH, Hong D, Osheroff N (1993) J Biol Chem 268: 14394-8 The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells. Mayer IA, Verma A, Grumbach IM, Uddin S, Lekmine F, Ravandi F, Majchrzak B, Fujita S, Fish EN, Platanias LC (2001) J Biol Chem 276: 28570-7 Urinary excretion of isoflavonoids and the risk of breast cancer. Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Franke AA (1999) Cancer Epidemiol Biomarkers Prev 8: 35-40 BIO 300, a Nanosuspension of Genistein, Mitigates Radiation-Induced Erectile Dysfunction and Sensitizes Human Prostate Cancer Xenografts to Radiation Therapy. Jackson IL, Pavlovic R, Alexander AA, Connors CQ, Newman D, Mahmood J, Eley J, Harvey AJ, Kaytor MD, Vujaskovic Z (2019) Int J Radiat Oncol Biol Phys 105: 400-409 Topoisomerase II and leukemia. Pendleton M, Lindsey RH, Felix CA, Grimwade D, Osheroff N (2014) Ann N Y Acad Sci 1310: 98-110 Assessment of dietary isoflavone intake among middle-aged Chinese men. Lee SA, Wen W, Xiang YB, Barnes S, Liu D, Cai Q, Zheng W, Shu XO (2007) J Nutr 137: 1011-6 Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II. Robinson MJ, Corbett AH, Osheroff N (1993) Biochemistry 32: 3638-43 Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Bandele OJ, Osheroff N (2007) Biochemistry 46: 6097-108 Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs. Elsea SH, Westergaard M, Burden DA, Lomenick JP, Osheroff N (1997) Biochemistry 36: 2919-24 Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes. Osheroff N, Corbett AH, Elsea SH, Westergaard M (1994) Cancer Chemother Pharmacol 34 Suppl: S19-25 IL-6 production in human intestinal epithelial cells following stimulation with IL-1 beta is associated with activation of the transcription factor NF-kappa B. Parikh AA, Salzman AL, Kane CD, Fischer JE, Hasselgren PO (1997) J Surg Res 69: 139-44 Complement component C3 production in IL-1beta-stimulated human intestinal epithelial cells is blocked by NF-kappaB inhibitors and by transfection with ser 32/36 mutant IkappaBalpha. Moon MR, Parikh AA, Pritts TA, Fischer JE, Cottongim S, Szabo C, Salzman AL, Hasselgren PO (1999) J Surg Res 82: 48-55 Tyrosine kinase inhibition affects type 1 angiotensin II receptor internalization. Becker BN, Kondo S, Chen JK, Harris RC (1999) J Recept Signal Transduct Res 19: 975-93
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.